Nexpep (Discovery Platform) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Nexpep (Discovery Platform) General Information
Description
Developer of an immunotherapeutic vaccine, companion diagnostic and monitoring tool for celiac disease. The company develops treatment designed to replace a gluten-free diet for coeliac disease sufferers.
Contact Information
Corporate Office
- Australia
Corporate Office
- Australia
Nexpep (Discovery Platform) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nexpep (Discovery Platform) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nexpep (Discovery Platform) FAQs
-
Where is Nexpep (Discovery Platform) headquartered?
Nexpep (Discovery Platform) is headquartered in Australia.
-
What industry is Nexpep (Discovery Platform) in?
Nexpep (Discovery Platform)’s primary industry is Drug Discovery.
-
Is Nexpep (Discovery Platform) a private or public company?
Nexpep (Discovery Platform) is a Private company.
-
What is Nexpep (Discovery Platform)’s current revenue?
The current revenue for Nexpep (Discovery Platform) is .
-
Who are Nexpep (Discovery Platform)’s investors?
Nexpep has invested in Nexpep (Discovery Platform).
-
When was Nexpep (Discovery Platform) acquired?
Nexpep (Discovery Platform) was acquired on 15-Mar-2011.
-
Who acquired Nexpep (Discovery Platform)?
Nexpep (Discovery Platform) was acquired by ImmusanT.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process